NEUARTIGE THROMBININHIBITOREN
European patent · EP3310807 · In force
Register entry
- Publication number
- EP3310807
- Application number
- EP16812056
- Kind
- European patent with effect for Switzerland and Liechtenstein
- Status
- In force
- Specification
- Granted
- Filed
- Jun 17, 2016
- Published
- Apr 25, 2018
- Granted
- May 13, 2020
- Protection ends at the latest
- Jun 16, 2036
- Next annual fee due
- Jun 30, 2026
- IPC classes
- C07K 14/81 (2006.01)C07K 7/08 (2006.01)C07H 21/04 (2006.01)A61K 38/57 (2006.01)A61K 38/10 (2006.01)A61P 7/02 (2006.01)
- Priority
- US 201562230923 P 18.06.2015
- PCT application
- PCT/SG2016/050278 17.06.2016
- PCT publication
- WO2016/204696 22.12.2016
- Filing language
- English
- Source
- Swissreg
History
What the Federal Institute of Intellectual Property published about this title, newest first.
- Jul 18, 2025
Change
Published in Swissreg on 18.07.2025
- Jul 9, 2024
Change
Published in Swissreg on 09.07.2024
- Jul 1, 2023
Change
Published in Swissreg on 01.07.2023
- Jan 9, 2023
Address changed
- Representative
- ServoPatent GmbH, Wannerstrasse 9/1, 8045 Zürich → Servopatent GmbH, Bühlstrasse 1, 8125 Zollikerberg
Published in Swissreg on 09.01.2023
- Jun 30, 2022
Change
Published in Swissreg on 30.06.2022
- Aug 12, 2020
Agent entered
- Representative
- ServoPatent GmbH, Wannerstrasse 9/1, 8045 Zürich
Published in Swissreg on 12.08.2020
- May 13, 2020
Granted
Published in Swissreg on 13.05.2020
Parties
Holder
Inventor
Singapore 119077, SG
Singapore 119077, SG
845 06 Bratislava, SK
Singapore 119077, SG
845 06 Bratislava, SK
The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.